FindTrial
Sign In

Decidual vasculopathy in preeclampsia 3: Prediction and early detection

Decidual vasculopathy in preeclampsia 3: Prediction and early detection - DEVAP 3

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON35148
Enrollment
70
Registered
2012-02-10
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HELLP syndrome preeclampsia

Interventions

None listed

Sponsors

Universitair Medisch Centrum Sint Radboud
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Adult pregnant women at 11-13 weeks gestational age

Exclusion criteria

Exclusion criteria: Multiple pregnancies, cases with intra-uterine infections, cases with chromosomal abnormalities of the fetus (determined by karyotype, diagnostics will not be performed as part of this study)

Design outcomes

Primary

MeasureTime frame
The aim of this study is storage of material and ultrasonic data. Subsequently, a larger study will be designed aimed to develope a tool for the prediction of preeclampsia and decidual vasculopathy. In this future study, the parameters will be levels of biomarkers and measurements of uterine artery flow.—

Secondary

MeasureTime frame
Not applicable.—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)